An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This exploratory, 12-month, ascending-dose study will evaluate the safety and effects on
visual function of a single injection of Brimonidine intravitreal implant in one eye of
patients with Retinitis Pigmentosa.